Source link : https://newshealth.biz/health-news/low-dose-apixaban-best-for-long-term-use-in-cancer/
Extended therapy with reduced-dose apixaban is just as effective as the high dose in preventing recurrent venous thromboembolism (VTE) in patients with active cancer who completed at least 6 months of anticoagulant treatment after a clot, and results in a lower rate of clinically relevant bleeding, the API-CAT trial shows. “Our results indicate that cancer […]
The post Low-Dose Apixaban Best for Long-Term Use in Cancer first appeared on News Health.
Author : News Health
Publish date : 2025-03-30 20:06:00
Copyright for syndicated content belongs to the linked Source.
in Health